Skip to main content
. Author manuscript; available in PMC: 2020 Sep 17.
Published in final edited form as: J Rheumatol. 2018 Sep 15;46(1):106–111. doi: 10.3899/jrheum.180353

Table 3.

Comparison between DM, PM, and other patients.

Domains Total, n = 510 DM, n = 238 PM, n = 212 Others, n = 60 p
1 Muscle symptoms 3.43 ± 1.88 3.34 ± 1.91 3.7 ± 1.75 2.85 ± 2.04 0.005
2 Fatigue 1.89 ± 1.78 1.89 ± 1.76 1.85 ± 1.81 2.02 ± 1.76 0.823
3 Pain 1.33 ± 1.83 1.39 ± 1.8 1.27 ± 1.84 1.28 ± 1.97 0.752
4 Lung symptoms 1.03 ± 1.78 0.83 ± 1.62 0.95 ± 1.73 2.1 ± 2.18 < 0.0001
5 Skin symptoms 0.96 ± 1.64 1.78 ± 1.95 0.25 ± 0.81 0.23 ± 0.79 < 0.0001
6 Levels of physical activity 0.91 ± 1.4 0.71 ± 1.23 1.11 ± 1.53 1 ± 1.45 0.009
7 Medication side effects 0.79 ± 1.37 0.63 ± 1.21 0.96 ± 1.5 0.88 ± 1.43 0.033
8 Dysphagia 0.7 ± 1.45 0.79 ± 1.45 0.64 ± 1.45 0.58 ± 1.44 0.440
9 Cognitive impact 0.56 ± 1.25 0.58 ± 1.26 0.54 ± 1.22 0.58 ± 1.34 0.940
10 Increased risk of infection 0.47 ± 1.11 0.52 ± 1.17 0.38 ± 0.97 0.63 ± 1.28 0.218
11 Joint symptoms 0.41 ± 1.05 0.4 ± 1.06 0.4 ± 1.03 0.5 ± 1.11 0.786
12 Difficulty sleeping 0.4 ± 1.02 0.35 ± 0.99 0.48 ± 1.09 0.33 ± 0.9 0.380
13 Work ability 0.32 ± 0.91 0.23 ± 0.71 0.38 ± 1.01 0.45 ± 1.16 0.094
14 Gastrointestinal tract symptoms 0.3 ± 0.94 0.29 ± 0.99 0.34 ± 0.92 0.22 ± 0.78 0.654
15 Emotional distress 0.29 ± 0.88 0.26 ± 0.89 0.33 ± 0.9 0.23 ± 0.74 0.676
16 Cardiovascular symptoms 0.28 ± 0.97 0.26 ± 0.91 0.35 ± 1.1 0.13 ± 0.6 0.252
17 Interaction* 0.2 ± 0.82 0.18 ± 0.79 0.23 ± 0.88 0.22 ± 0.72 0.774
18 Dryness of eyes and/or mouth 0.18 ± 0.66 0.23 ± 0.79 0.13 ± 0.5 0.17 ± 0.56 0.307
19 Incontinence 0.11 ± 0.56 0.06 ± 0.43 0.18 ± 0.69 0.08 ± 0.53 0.057
20 Relation and/or intimacy 0.11 ± 0.53 0.1 ± 0.49 0.12 ± 0.52 0.13 ± 0.7 0.856
21 Leisure activities 0.09 ± 0.45 0.04 ± 0.33 0.16 ± 0.56 0.07 ± 0.36 0.017
22 Household activities 0.09 ± 0.44 0.06 ± 0.31 0.1 ± 0.45 0.18 ± 0.75 0.140
23 Personal care 0.07 ± 0.45 0.08 ± 0.45 0.06 ± 0.45 0.08 ± 0.42 0.919
24 Social gathering 0.05 ± 0.34 0.01 ± 0.13 0.09 ± 0.49 0.03 ± 0.18 0.037

Values are mean ± SD.

Others included necrotizing autoimmune myopathies and the antisynthetase syndrome patients.

*

Interaction with healthcare personnel and authorities. Values in bold face are statistically significant. DM: dermatomyositis; PM: polymyositis.